Cargando…
Next Steps for Immunotherapy in Glioblastoma
SIMPLE SUMMARY: Prognosis for glioblastoma patients remains poor despite the current standard of care treatments. More recent investigations have focused on immunotherapy, which utilizes a patient’s immune system to target cancer cells. Though proven to be successful in non-central nervous system ca...
Autores principales: | Cao, Toni Q., Wainwright, Derek A., Lee-Chang, Catalina, Miska, Jason, Sonabend, Adam M., Heimberger, Amy B., Lukas, Rimas V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406905/ https://www.ncbi.nlm.nih.gov/pubmed/36011015 http://dx.doi.org/10.3390/cancers14164023 |
Ejemplares similares
-
Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapy
por: Sonabend, Adam M., et al.
Publicado: (2021) -
Myeloid Cell Classification and Therapeutic Opportunities Within the Glioblastoma Tumor Microenvironment in the Single Cell-Omics Era
por: Larkin, Collin J., et al.
Publicado: (2022) -
Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment
por: Arrieta, Víctor A., et al.
Publicado: (2023) -
The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma
por: Sooreshjani, Moloud, et al.
Publicado: (2023) -
The kynurenine pathway implicated in patient delirium: possible indications for indoleamine 2,3 dioxygenase inhibitors
por: Heimberger, Amy B., et al.
Publicado: (2023)